Thermo Fisher announces FDA approved Oncomine Dx Express Test

Thermo Fisher (TMO) Scientific announced the U.S. Food and Drug Administration, FDA, has approved the Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer as an in vitro diagnostic assay for use as a companion diagnostic for Dizal’s ZEGFROVY and in tumor profiling. This approval brings rapid next-generation sequencing to decentralized clinical settings closer to where patients receive care.